|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01515 CR MEDICAL
Nominal 
3.820 +0.070 (+1.867%) Profitability Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| ROAA (%) | 4.196% | 1.638% | 1.880% | 4.302% | 3.684% |
| ROAE (%) | 9.411% | 3.364% | 3.332% | 6.657% | 5.165% |
| Return on Capital Employed (%) | 6.417% | 3.051% | 2.094% | 5.950% | 4.590% |
Margin Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Gross Profit Margin (%) | 18.365% | 18.856% | 16.527% | 20.991% | 23.140% |
| EBITDA Margin (%) | 14.410% | 10.482% | 10.113% | 6.974% | 15.780% |
| Pre-tax Profit Margin (%) | 8.510% | 4.877% | 5.353% | 6.082% | 15.203% |
| Net Profit Margin (%) | 5.742% | 2.549% | 3.365% | 9.397% | 11.275% |
Liquidity Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Current Ratio (X) | 0.720 X | 0.659 X | 1.320 X | 1.140 X | 1.879 X |
| Quick Ratio (X) | 0.653 X | 0.600 X | 1.249 X | 1.086 X | 1.814 X |
Leverage Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Total Liabilities / Total Assets(%) | 43.700% | 48.638% | 40.206% | 34.594% | 29.261% |
| Total Debt / Total Assets (%) | 11.981% | 16.928% | 13.480% | 16.512% | 8.373% |
| Net Debt / Total Assets (%) | 4.642% | 7.875% | -3.919% | -5.691% | -21.766% |
| Total Debt / Shareholders' Funds (%) | 25.679% | 39.769% | 25.265% | 26.793% | 12.292% |
| Long Term Debt / Shareholders' Funds (%) | 13.550% | 17.008% | 11.072% | 0.624% | 0.766% |
| Net Debt / Shareholders' Funds (%) | 9.950% | 18.501% | -7.346% | -9.234% | -31.953% |
| Net Cash / (Debt) ($) | (618.269M) | (1.075B) | 698.288M | 595.677M | 1.951B |
| Net Cash / (Debt) per share ($) | (0.477) | (0.829) | 0.539 | 0.459 | 1.505 |
| Total Debt / Capital Employed (%) | 18.093% | 27.364% | 18.921% | 24.607% | 11.108% |
| Interest Coverage Ratio (X) | -- | 5.291 X | 8.566 X | 17.661 X | 25.572 X |
Efficiency Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Inventory Turnover (Day) | 13.696 Day | 14.899 Day | 15.289 Day | 16.989 Day | 17.623 Day |
| Receivables Turnover (Day) | 54.590 Day | 54.643 Day | 52.137 Day | 56.821 Day | 82.059 Day |
| Payables Turnover (Day) | 63.478 Day | 62.578 Day | 59.173 Day | 57.108 Day | 53.438 Day |
| Remarks: | Real time quote last updated: 16/05/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 565,875 |
| %Change | 119.604% |
| EPS / (LPS) | RMB 0.450 |
| NBV Per Share (¥) | RMB 4.792 |